Illumina, Inc.
ILMN
$200.66-9.35 (4.45%)Nov 19
After-hours: $197.25 (-1.70%)
Illumina, Inc. (ILMN)
$200.66-9.35-4.45%Nov 19
Loading chart…
YTD53%
M.cap.30.3 bn
Std.Dev, 1y0.59
Vol, bn0.3 (med)
RSI34
P/E36.6
MFI39
P/S6.60
ADX14 (no trend)
P/B9.65
Beta1.49
Div—
Debt/EBITDA1.80
Payout—
Price target
Buy 10 (67%)Hold 3 (20%)Sell 2 (13%)
Next earnings4 Feb, after close
Earnings surprise
Short interest5.3% (+0.1%), 30 Oct 2026
Fund owners #951 (-26)
Insider ownership$172 mm
Insider sellingVery High
Insider buying—
General
M.Cap$30.3B
Dividends—
Next report4 Feb, after close
Forecast
Valuation
Target
P/E36.6
P/S6.60
P/B9.65
Fundamentals
5-y avg sales growth+6.0%
Debt / EBITDA1.80
ROE31.2%
Altman Z-score4.47 (safe)
Technicals
RSI34
MFI39
Price / MA50-19.3% (v.low) ↓
Trend pattern
Financial Statements
No data available
Financial Statements
No data available
Team
Loading…
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Investor Presentations
Loading…
Options
Exp. from:to:
Strike from:to:
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
Stress Test
Loading…
About

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis, serving customers in various markets involved in research and clinical settings for applications in life sciences, oncology, reproductive health, and more. The company sells instruments, consumables, genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as testing services. Illumina's customers include various research centers, academic institutions, hospitals, commercial molecular diagnostic laboratories, and more, and the company markets and sells its products directly to customers worldwide.

WikipediaHeadcount: 8,600
Address:5200 Illumina Way, San Diego, CA, United States, 92122
About

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis, serving customers in various markets involved in research and clinical settings for applications in life sciences, oncology, reproductive health, and more. The company sells instruments, consumables, genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as testing services. Illumina's customers include various research centers, academic institutions, hospitals, commercial molecular diagnostic laboratories, and more, and the company markets and sells its products directly to customers worldwide.

https://www.illumina.com
Beta 1.49